1. 1. Meusel, L, Kansal, N, Tchistiakova, E, Yuen W, MacIntosh, B, Greenwood, C, et al. A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms. Front Aging Neurosci 2014.6: 148. [DOI:10.3389/fnagi.2014.00148]

2. Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S. Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2011;1: 316-322. [DOI:10.1016/S2221-1691(11)60051-8]

3. Scherbaum WA. Insulin therapy in Europe-Diabetes. Metab Res Rev 2002; 3: 3:S50-6. [DOI:10.1002/dmrr.298]

4. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14. [DOI:10.1016/j.diabres.2009.10.007]

5. Nolte MS, Karam JH, ed. Pancreatic hormones and antidiabetic drugs. Basic and clinical pharmacology. 9th ed. New York: McGraw Hill Companies; 2004. P.708.

6. Hald A, Lotharius J. Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 2005;193:279-90. [DOI:10.1016/j.expneurol.2005.01.013]

7. Venkatesh S, Reddy GD, Reddy BM, Ramesh M, Rao AV. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia 2003; 74:274-9. [DOI:10.1016/S0367-326X(03)00021-2]

8. McCune LM, Johns T. Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the North American boreal forest. J Ethnopharmacol 2002;82:197-205. [DOI:10.1016/S0378-8741(02)00180-0]

9. Fallah Huseini H, Fakhrzadeh H, Larijani B, Shikh Samani A. Review of anti-diabetic medicinal plant used in traditional medicine. J Med Plants 2006; 1 :1-8 [In Persian]

10. Hajinejad MR, Salehi Moghadam M, Hajian Shahri S, Vaezi E, Jamshidian A, Sa'atati D. Effect of Carla leaf extract on serum glucose, lipid and malondialdehyde levels in streptozocin-induced diabetic rats. Diabetes Nur 2014;2:8-19. [In Persian]

11. Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem 2004;261:63-70. [DOI:10.1023/B:MCBI.0000028738.95518.90]

12. Yibchok-anun S, Adisakwattana S, Yao CY, Sangvanich P, oengsumran S, Hsu WH. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull 2006;29:1126-31. [DOI:10.1248/bpb.29.1126]

13. Huang QY, Cheng MR, Ji SL. Linkage and association studies of the susceptibility genes for type 2 diabetes. Yi Chuan Xue Bao 2006; 33:573-89. [DOI:10.1016/S0379-4172(06)60087-5]

14. Patlak M. New weapons to combat at ancient disease: treating diabetes. FASEB J. 2002:16:1853. [DOI:10.1096/fasebj.16.14.1853e]

15. Qiu Li, Zhi-Chun Lai. Recent progress in studies of factors that elicit pancreatic β-cell expansion. Protein Cell 2015; 6: 81-87. [DOI:10.1007/s13238-014-0123-3]

16. Rukstalis JM, Habener JF. Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets 2009;1:177-184. [DOI:10.4161/isl.1.3.9877]

17. Gomez DL, O'Driscoll M, Sheets TP, Hruban RH, Oberholzer J, McGarrigle JJ, et al. Neurogenin 3 expressing cells in the human exocrine pancreas have the capacity for endocrine cell fate. PLoS One 2015;10:e0133862. doi:10.1371/journal.pone.0133862. [DOI:10.1371/journal.pone.0133862]

18. Pagliuca FW, Melton DA. Melton. How to make a functional β-cell. Development 2013;140:2472-83. [DOI:10.1242/dev.093187]

19. Khaleghi S, Bahrami G, Mahmoodi M, Asgari V, Mostafaie A. Hypoglycemic Effect of Hydroalcoholic Extract and Hexane Fraction of Persian Shallot (Allium Hirtifolium Boiss) Extract in Streptozotocin-Induced Diabetic Rats. JRPS. 2015; 5: 33-40.

20. Kermany H, Shahanipour K, Nakhaee AR. Effect of aqueous and methanolic extracts of Momordica charantia fruit on blood glucose and liver enzymes in diabetic rats. Quarterly of the Horizon of Medical Sciences 2015; 21:105-112. [In Persian] [DOI:10.18869/acadpub.hms.21.2.105]

21. Abdollahi M, Zuki ABZ, Goh YM, Rezaeizadeh A, Noordin MM. The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. Afr J Biotechnol 2011;26:13-21.

22. Ahangaran, A, Mosahebi Mohammadi G, Koohi Habibi M, Khezri S, Shahraeen, N. Use of rapid serological and nucleic acid-based methods for detecting the soybean mosaic virus. J Agric Sci Technol 2009.11: 91-97.

23. Al-said MS, Abdelsattar EA, Khalifa SI, EI- Feraly FS. Isolation and identification of an anti- inflammatory principle from Capparis spinosa. Pharmazie 1988; 43: 640-41.

24. Lenzen S. The mechanisms of alloxan and STZ- induced diabetes. Diabetologia 2008;51:216-226. [DOI:10.1007/s00125-007-0886-7]

25. Rethod NR. Chime HR. Hypoglycemic effect of calotropis gigantean linn.Leaves and flowers in STZ-diabetic rats. J Oman Med 2011; 26:104-108. [DOI:10.5001/omj.2011.26]

26. Ardestani A, Yazdanparast R, Jamshidi Sh. Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats. Med Food 2008; 11: 525-32. [DOI:10.1089/jmf.2006.0230]

27. Kavalali G. Tuncel H. Hatmi HH. Hypoglycemic activity of Urtica pilulifera in pilulifera in STZ-diabetic rats. J Ethnopharmacol 2003;84:241-245. [DOI:10.1016/S0378-8741(02)00315-X]

28. Baboota, S. Kohli, K. Ahmad, S. Ali, J. Silymarin: a review of Pharmalogical aspects and bioavilability enhancement approaches. Indian J Pharamacol 2007; 39:172-179. [DOI:10.4103/0253-7613.36534]

29. Kaushik U, Aeri V, Mir SR. Cucurbitacins - An insight into medicinal leads from nature. Pharmacogn Rev 2015;9:12-8. [DOI:10.4103/0973-7847.156314]

30. Hussain F, Tahira S. Antidiabetic evaluation of Momordica charantia L fruit extracts. West Indian Med J 2014; 63:294-99.

31. Gheibi S, Bakhtiarzadeh F, Ghasemi A. A review of high fat diet-streptozotocin model for induction of type 2 diabetes in rat. Iranian Journal of Endocrinology and Metabolism 2016; 18:135-148. [In Persian]